Conference-Service.com offers, as part of our business activities, a directory of upcoming scientific and technical meetings. The calendar is published for the convenience of conference participants and we strive to support conference organisers who need to publish their upcoming events. Although great care is being taken to ensure the correctness of all entries, we cannot accept any liability that may arise from the presence, absence or incorrectness of any particular information on this website. Always check with the meeting organiser before making arrangements to participate in an event!
Meeting organisers can submit meetings free of charge for inclusion into the listing.
The NGBT conference is jointly hosted with Centre for the Commercialization of Antibodies and Biologics (CCAB), Toronto, Canada, Tata Institute of Fundamental Research (TIFR Biology Department), Mumbai, India, and Institute of Bioinformatics (IOB), Bengaluru, India. This is the sixth international conference that is hosted by SGRF Conferences, the educational outreach arm of SciGenom Research Foundation (SGRF), along with national institutes in India.
The genome editing market represents a rapidly evolving area of pharmaceutical research since the discovery of the CRISPR/Cas systems that have revolutionised biological research. Significant advancements have been made in the fields of improving genome editing tools & technologies, gene delivery systems and utilising genome editing for therapeutic applications. Genomics research is experiencing an increased funding and thanks to the technological advancements the genome editing market is expected to grow rapidly. Experts have also highlighted that the global market for genome editing is expected to reach over $2.0 billion by 2020.
In the past few years, exceptional progress has been made in the application of genetics- and genomics-based technologies in biomedical research. There are currently thousands of DNA variants that are robustly associated with clinically relevant human traits. Although these should provide a rich source of molecular starting points for drug discovery, and a deeper understanding of their role in human physiology, the translation of these data from large-scale projects has been slow to influence the selection and validation of new targets in drug discovery and development programmes.
This meeting will bring together researchers based in academia and industry to focus on the opportunities and challenges for genomics in drug discovery. Epidemiology, molecular biology and computational approaches will be covered with a focus on contributions these methods can offer to the development of new therapies to treat patients. The potential of human cellular assays that can be perturbed genetically (by RNAi or CRISPR) or chemically will also be emphasised.
Its 3 day event which includes Keynote sessions, featured speakers, students, companies. We encourage delegates to use this conference as a meeting place to assemble their academic interest-groups for global deliberations.
Last updated: 24 July 2016